These emerging therapies, including Semaglutide , belong to a category of drugs called GLP-1 agents. Primarily approved for treating type 2 diabetes , they work by assisting the pancreas to release https://www.how-dept.com/mayiknow/detail/?p=Does-a-No-Membership-Fee-Model-Save-Money-on-GLP-1-Over-Time--AVYszP4br5XSf